PHARMA

Neuland Laboratories Ltd shares jump 1.43% as disclosure under SEBI regulations for Malabar India Fund received

By Chandra Shekar •
On August 14, 2026, Malabar India Fund Ltd disclosed to Neuland Laboratories that it acquired a 1.52% stake, crossing the 6% shareholding threshold under SEBI regulations.

Why did Neuland Laboratories Ltd shares jump today?

Neuland Laboratories Ltd shares witnessed a notable upward movement today, rising by 1.43%. The stock was trading at ₹23,644.4 at 2:08 PM on Monday, indicating positive investor sentiment around the company during the session.

The trigger for this price action appears to be a regulatory disclosure received by the stock exchanges. Malabar India Fund Limited, a Mauritius-based investor, informed BSE and NSE that it had sold 2,72,634 equity shares of Neuland Laboratories in the secondary market. This transaction was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as required for significant changes in shareholding.

Importantly, the disclosure clarifies that Malabar India Fund is not part of the promoter or promoter group of Neuland Laboratories. Such disclosures by institutional investors are routine compliance procedures. The market may be reacting positively, interpreting this as a normal portfolio rebalancing by a financial investor rather than a negative signal about the company's fundamentals. This transparency, combined with the stock's trading activity, contributed to the positive price movement observed today.

What does Neuland Laboratories Ltd do?

Based on the information available, Neuland Laboratories Ltd is a company whose equity shares are traded in the secondary market in India. The document details a transaction involving the sale of its shares.

Neuland Laboratories Ltd Financials

In Crores
776
213
Mar 2026
642
148
Jun 2026
Revenue
Net Profit

Neuland Laboratories Ltd's financials show a decline in both revenue and profit from the quarter ending March 2026 to the quarter ending June 2026. Revenue decreased from ₹776.25 Crores to ₹641.58 Crores, while net profit also fell from ₹212.67 Crores to ₹147.67 Crores, indicating a quarter-over-quarter contraction in both top-line and bottom-line performance.

Neuland Laboratories Ltd Shareholding Pattern

Holdings
Promoter
32.62%
FIIs
21.08%
DIIs
16.52%
Public
29.79%

Promoter holding stands at 32.62% of the total share capital. Foreign Institutional Investors (FIIs) hold 21.08% stake in the company, while Domestic Institutional Investors (DIIs) hold 16.52%. Public shareholders hold the remaining 29.79% stake in Neuland Laboratories Ltd.

Neuland Laboratories Ltd FAQs

Q: Why did Neuland shares jump 1.43% today?

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Malabar India Fund Ltd. This corporate action caught investor attention, leading to increased trading activity in the stock.

Q: What is the shareholding pattern of Neuland Laboratories Ltd?

As per the latest data, promoters hold 32.62% stake in Neuland Laboratories Ltd, while FII holding stands at 21.08%. Domestic institutional investors hold 16.52%, and public shareholders account for 29.79% of the equity.

Q: What is the current stock price of Neuland Laboratories Ltd?

Neuland Laboratories Ltd shares are currently trading at ₹23644.4, recording a gain of 1.43% from the previous close.

Q: What is the market capitalization of Neuland Laboratories Ltd?

The company currently has a market capitalization of ₹30335.5 crore, reflecting its valuation in the Indian equity market.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. The stock prices mentioned are as of the time of writing. Chandra Shekar and the publisher do not hold any positions in the stocks mentioned. Please consult a SEBI-registered financial advisor before making any investment decisions.